Aromatase inhibitors (AIs) are the most controversial tool in TRT management. Once prescribed routinely alongside testosterone, their use is now being reconsidered as clinicians recognize that crashing estrogen causes more problems than it solves. This guide covers the three available AIs, how they work, when they're genuinely necessary, and why less is almost always more.
How Aromatase Inhibitors Work
Aromatase is the enzyme that converts testosterone (and other androgens) to estradiol (and other estrogens). It's found primarily in adipose tissue, with smaller amounts in the brain, bones, blood vessels, and testes.
Aromatase inhibitors block this enzyme, reducing estradiol production. The three AIs available differ in their mechanism:
Type 1: Steroidal (Irreversible)
Exemestane (Aromasin) permanently inactivates the aromatase enzyme. Each molecule of exemestane destroys one molecule of aromatase. The body must produce new aromatase enzymes to replace the inactivated ones. This gives exemestane a unique property: its effects are more gradual and less likely to cause dramatic estradiol crashes compared to the other AIs.
Type 2: Non-Steroidal (Reversible)
Anastrozole (Arimidex) and Letrozole (Femara) reversibly bind to the aromatase enzyme, blocking its active site. When the drug clears the system, the enzyme resumes function. This means effects are dose-dependent and more predictable, but also means that missing doses or changing frequency can cause rapid estradiol fluctuations.
The Three AIs Compared
Anastrozole (Arimidex)
The most commonly prescribed AI for TRT.
Mechanism: Reversible aromatase inhibition. Reduces estradiol by approximately 50-70% at standard doses.
Half-life: Approximately 46-50 hours.
Typical TRT dosing: 0.125-0.5mg twice weekly. Many men do well with just 0.125mg (an eighth of a 1mg tablet) twice weekly. The standard "1mg per week" dose that many clinics prescribe is often too much.
Dosing approaches:
| Scenario |
Starting Dose |
Adjustment |
| Mildly elevated E2 (40-50 pg/mL) with symptoms |
0.125mg twice weekly |
Recheck in 4-6 weeks |
| Moderately elevated E2 (50-70 pg/mL) with symptoms |
0.25mg twice weekly |
Recheck in 4-6 weeks |
| Significantly elevated E2 (>70 pg/mL) with symptoms |
0.5mg twice weekly |
Recheck in 4 weeks |
Advantages:
- Most clinical data available
- Widely available as generic (very affordable, $10-30/month)
- Dose can be precisely titrated
- Reversible -- effects wear off within 3-5 days of stopping
Disadvantages:
- Easy to overshoot and crash estradiol
- Negative impact on lipid profiles (reduces HDL, may increase LDL)
- Joint pain at higher doses
- Does not favorably alter the androgen-to-estrogen ratio as well as exemestane
Letrozole (Femara)
The most potent AI -- and the most dangerous for TRT use.
Mechanism: Reversible aromatase inhibition. Reduces estradiol by approximately 75-95% at standard oncology doses.
Half-life: Approximately 48 hours.
Why it's rarely appropriate for TRT: Letrozole is designed for aggressive estrogen suppression in post-menopausal breast cancer. A standard 2.5mg dose can drive male estradiol to undetectable levels within days. Even at micro-doses (0.25-0.5mg per week), the potency makes it difficult to achieve stable, moderate estradiol reduction.
When it might be used: Occasionally prescribed for men with extremely high aromatase activity who don't respond adequately to anastrozole. This is rare. If your provider is starting you on letrozole as a first-line AI with TRT, get a second opinion.
Typical TRT dosing (if used at all): 0.25mg once or twice per week. This still represents aggressive suppression.
Exemestane (Aromasin)
The AI with the most favorable profile for TRT use, though less commonly prescribed.
Mechanism: Irreversible (suicidal) aromatase inactivation. Permanently destroys the enzyme rather than temporarily blocking it.
Half-life: Approximately 24 hours. But because it permanently inactivates aromatase, the effective duration is longer -- the body needs to synthesize new enzyme, which takes roughly 2-3 days.
Typical TRT dosing: 6.25-12.5mg twice weekly. Standard exemestane tablets are 25mg, so most TRT patients use a quarter to a half tablet.
Advantages over anastrozole:
- Being a steroidal AI, exemestane is mildly androgenic itself. It doesn't have the same negative impact on lipid profiles that anastrozole does. Some studies show exemestane may actually improve or maintain HDL cholesterol.
- Less likely to cause dramatic estradiol crashes due to its mechanism (gradual enzyme depletion rather than immediate blockade)
- May slightly increase IGF-1 levels
- Doesn't bind to SHBG, so it doesn't affect testosterone binding dynamics
Disadvantages:
- Must be taken with fat for absorption (bioavailability increases 40% with a fatty meal)
- Less widely prescribed for TRT, so fewer providers are familiar with its dosing
- Slightly more expensive than generic anastrozole
- Irreversibility means if you take too much, recovery takes longer
Why Less Is More
The most common AI mistake in TRT is taking too much. Here's why conservative dosing is critical:
The Estrogen Crash
When estradiol drops below approximately 15 pg/mL, men experience a constellation of symptoms that are often worse than the high-estrogen symptoms they were trying to treat:
- Severe joint pain and stiffness (the most consistent symptom)
- Depression, flatness, anhedonia
- Complete loss of libido
- Fatigue that doesn't respond to rest
- Dry eyes and skin
- Anxiety and insomnia
- Bone pain
A crashed estradiol takes 2-4 weeks to recover from after stopping the AI. During that time, you feel terrible and there's no shortcut. You simply have to wait for aromatase enzyme to rebuild and estradiol production to resume.
This is why starting with the lowest possible dose and titrating up slowly is so important. You can always increase an AI dose. Recovering from too much takes weeks of misery.
Impact on Lipid Profiles
Anastrozole and letrozole (the non-steroidal AIs) consistently worsen lipid profiles in men on TRT. Studies have shown:
- HDL cholesterol decreases by 5-15% on typical TRT anastrozole doses
- The protective cardiovascular effects of estradiol are diminished
- LDL may increase modestly
Given that cardiovascular health is already a monitoring priority on TRT, adding a drug that worsens lipid profiles requires strong justification. If exemestane is an option for your situation, its lipid-neutral profile makes it a better choice.
Bone Density Concerns
Long-term estrogen suppression in men (even partial) carries bone density risk. Estradiol is the primary driver of bone mineral density in men. Chronically keeping estradiol at the low end of the range (or below) with an AI increases long-term osteoporosis risk, particularly in older men.
This is not a concern with short-term or low-dose AI use. But men who take AIs at moderate-to-high doses for years should have bone density monitoring (DEXA scans) added to their protocol.
When an AI Is Truly Necessary
Despite everything above, there are legitimate clinical scenarios:
1. Symptomatic Gynecomastia
If you have nipple tenderness and palpable tissue development that is progressing despite optimizing injection frequency and dose, an AI is appropriate. Early gynecomastia (tissue proliferation stage) can be reversed with estrogen reduction. Established, fibrous gynecomastia requires surgery.
For acute gynecomastia management, some providers add a SERM (selective estrogen receptor modulator) like tamoxifen (20mg daily) rather than an AI. Tamoxifen blocks estrogen at the breast receptor without lowering systemic estradiol -- a more targeted approach.
2. Persistently Symptomatic High Estradiol
If estradiol remains above 50-60 pg/mL with symptoms (water retention, mood disturbance, sexual dysfunction) after you've:
- Increased injection frequency to EOD or daily
- Reduced total testosterone dose to the minimum effective level
- Addressed body composition (reducing body fat)
- Confirmed results with the sensitive estradiol assay
Then an AI at the lowest effective dose is reasonable. Some men are genetically high aromatizers and genuinely need pharmaceutical support.
3. Bridge Therapy
An AI can serve as a short-term bridge while you make protocol changes. For example, switching from weekly to daily injections takes 4-6 weeks to show full estrogen benefit. A low-dose AI during that transition period can manage symptoms while the frequency change takes effect. Taper and discontinue the AI once the new protocol stabilizes.
AI Dosing Protocol
If you and your provider determine an AI is necessary:
Step 1: Start Low
Begin with the lowest reasonable dose:
- Anastrozole: 0.125mg twice weekly
- Exemestane: 6.25mg twice weekly
Step 2: Wait and Recheck
Allow 4-6 weeks for steady state. Draw sensitive estradiol at trough along with testosterone labs.
Step 3: Adjust Minimally
If estradiol is still symptomatic, increase by the smallest increment available. For anastrozole, go from 0.125mg to 0.25mg twice weekly. For exemestane, from 6.25mg to 12.5mg twice weekly.
Step 4: Don't Chase a Number
The goal is symptom resolution, not hitting a specific estradiol number. If symptoms resolve at estradiol of 38 pg/mL, that's your target. Don't keep increasing the AI to push estradiol to 25 pg/mL.
Step 5: Reassess Periodically
Every 3-6 months, try tapering or reducing the AI. Body composition changes, protocol adjustments, and metabolic shifts may reduce your AI requirement over time. Some men who needed an AI initially can discontinue it after losing body fat and optimizing their injection protocol.
Lab Monitoring on an AI
| Test |
Frequency |
Purpose |
| Sensitive Estradiol |
Every 4-6 weeks during titration, then every 3-6 months |
Ensure estradiol stays above 15-20 pg/mL |
| Lipid Panel |
Every 6 months |
Monitor HDL/LDL impact |
| Total & Free Testosterone |
Same as estradiol schedule |
Context for estradiol interpretation |
| CBC |
Every 6 months |
Standard TRT monitoring |
| DEXA Scan |
Annually if on AI >12 months |
Bone density monitoring for chronic AI users |
Common Mistakes
Dosing AI Based on Testosterone Dose, Not Labs
"Take 0.5mg anastrozole for every 100mg testosterone" is a cookbook approach that ignores individual aromatase activity. Two men on 150mg/week can have estradiol levels of 25 and 65 pg/mL. One needs no AI; the other might. Always base AI decisions on actual estradiol labs and symptoms.
Using the Standard Estradiol Test
The standard immunoassay (ECLIA method) can overstate male estradiol by 20-30%. This leads to unnecessary AI prescriptions. Always use the sensitive estradiol test (LC/MS-MS) when making clinical decisions about estrogen management.
Not Trying Frequency Changes First
Jumping to an AI before trying EOD or daily injections misses the most effective non-pharmaceutical intervention. Increasing frequency from weekly to daily can reduce estradiol by 30-40% with zero side effects. If your provider jumps straight to an AI without adjusting frequency first, consider finding a clinic with more nuanced estrogen management.
Taking AI "Just in Case"
Prophylactic AI use -- taking it because you might get high estrogen -- is poor medicine. You're accepting definite side effects (lipid damage, bone risk, potential crash) to prevent a potential problem that may never materialize.
Refusing AI When Genuinely Needed
The opposite extreme is also problematic. If you have confirmed high estradiol with symptoms and have exhausted non-pharmaceutical strategies, refusing an AI on principle is stubborn, not informed. Use the tool when it's needed, at the lowest effective dose, and work to minimize or eliminate it over time.
The Bottom Line
Most men on TRT don't need an aromatase inhibitor. Of those who do, the majority need far less than they're prescribed. Start with protocol optimization (frequent injections, appropriate dose, body composition). If an AI is genuinely necessary, start at the lowest dose, monitor closely, and always prioritize symptom management over lab number chasing.
The best AI dose is the lowest one that keeps you symptom-free -- and ideally, the best AI dose is zero. A good clinic will optimize your injection frequency and dose before reaching for an AI -- see our independently scored clinic reviews.
Related Reading
This content is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting any treatment.